Clinical trial
An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping…
NCT00371813 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00371813 |
|---|---|
| Title | An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking |
| Official title | A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Multinational Study Of Efficacy And Safety Of Varenicline Tartrate For Smoking Cessation |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Smoking Cessation |
| Intervention type | Drug |
| Interventions | Varenicline tartrate, Placebo |
| Enrollment | 334 |
| Start date | Sep 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Sep 4, 2006 |
| Last update posted | Apr 22, 2015 |
| Countries | China, Singapore, Thailand |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: